Delay or failure of autologous bone marrow transplant

Delay or failure of autologous bone marrow transplant is a life-threatening hematologic complication in which a recipient of their own previously harvested hematopoietic stem cells experiences inadequate, delayed, or absent hematopoietic reconstitution following high-dose conditioning chemotherapy or radiotherapy Pathophysiologically driven by factors such as an insufficient stem cell dose, graft damage during manipulation or cryopreservation, microenvironmental stroma injury, or drug-induced my...

Delay or failure of autologous bone marrow transplant is a life-threatening hematologic complication in which a recipient of their own previously harvested hematopoietic stem cells experiences inadequate, delayed, or absent hematopoietic reconstitution following high-dose conditioning chemotherapy or radiotherapy

Affecting the hematopoietic and immune systems, this clinical state is defined by prolonged profound aplasia or the loss of sustained myeloid engraftment, characteristically marked by an absolute neutrophil count failing to recover above 500 cells/mm³ by the expected post-transplant window (typically by day 28) or dropping back into severe neutropenia following transient initial recovery

Affecting the hematopoietic and immune systems, this clinical state is defined by prolonged profound aplasia or the loss of sustained myeloid engraftment, characteristically marked by an absolute neutrophil count failing to recover above 500 cells/mm³ by the expected post-transplant window (typically by day 28) or dropping back into severe neutropenia following transient initial recovery

Pathophysiologically driven by factors such as an insufficient stem cell dose, graft damage during manipulation or cryopreservation, microenvironmental stroma injury, or drug-induced myelosuppression, the condition leaves patients severely vulnerable to life-threatening bacterial and fungal opportunistic infections, hemorrhagic complications, and mortality